Foresee Pharmaceuticals was listed on 18 August 2026 by the incransom ransomware group (the group's claim; Ransomware Tracker by ExposureDrift has not confirmed a breach). incransom listed 44 organizations that month and 1046 in total.
- Listed 94 days ago.
- 1198 organizations were listed by all groups in August 2026, see the month.
- 135 in Healthcare that month.
- 17 in TW that month.
Updated 2026-11-19 05:37 UTC. Data: public leak-site listings. How we work.
Foresee Pharmaceuticals
Threat Group Post & Evidence
- Listed by
- INC Ransom 1,046 listings in total
The listing states no data size and no ransom demand.
No capture of the original post
We only show a screenshot when we captured the group's own page ourselves. For this listing we have not, so none is shown.
The group's leak-site address is on paid plans
Free accounts see who listed this organization, when, and what the post claims. The address of the group's own page is shown to license-key holders. If you have a key, see what a license key adds.
What the group says it holds
Taken from the group's own post. Ransomware Tracker by ExposureDrift has not seen the data and cannot confirm any of this.
Foresee Pharmaceuticals Co., Ltd. https://www.foreseepharma.com Total leak: 1,2TB Leak includes: Drug Master File, ASMF, FDA/EMA, R&D, Financial statements, Clinical study reports and other confidential information. Projects: CAMCEVI, SIF, Casppian, NCE, Aderamastat, Linvemastat, FP-045, FP-016, FP-018, FP-014... Partners: Accord BioPharma, Intas Pharmaceuticals, Primevera Therapeutics, Accord Healthcare... Type of information: Confidential
Amounts as written
- 1,2TB
Plain-English summary AI-written
The group says it holds confidential information from Foresee Pharmaceuticals, including drug filings, research and development, financial statements, clinical study reports, and project and partner information.
Written by an AI model (openai/gpt-6-luna) from the post above. It can contain mistakes: rely on the quote, not the summary.
What to do about this listing
Choose who you are. Each step shows why it appears and, where we have one, its source. General guidance, not legal or incident-response advice.
If you work with Foresee Pharmaceuticals (customer, supplier or partner)
Within 3 days
- Do not open the group's page or download the data Do not visit the leak site or download files from a listing. Holding stolen data can be unlawful, and the files can carry malware. Wait for the company's own notice. Why: A safety rule for any leak listing.
- Ask Foresee Pharmaceuticals directly Write to your contact and ask whether your data, or your access to their systems, is in scope, and ask for a written statement. Your contract or data-protection law may oblige them to tell you if your data is affected: check the notification clause. Why: A listing is only the group's claim; the company is the one who can confirm what was taken.
- Review what Foresee Pharmaceuticals can reach of yours List the accounts, API keys, VPN or SSO connections and shared mailboxes this company has with you. Rotate the keys you gave them and remove access they do not need. Why: Access a supplier holds is how a listing about them can become a problem for you.
Within 30 days
- Keep watching Foresee Pharmaceuticals A supplier's listing can change after the first sighting: the group can add data, change the status or publish. Add the company to your supplier list to be told, and check your own domain too. Why: A listing is a moving claim, not a single event. Add to your supplier list Check your own domain
If you are Foresee Pharmaceuticals
Within 3 days
- Find out what was actually taken The post names no specific kind of data, so no data-specific steps are shown. Check the group's own post and your logs to learn what is claimed and what is real. Why: The listing text names no data types.
- Size the exposure against your own systems Inventory which systems hold data of the kind and volume claimed, so notification and legal decisions rest on your records rather than the group's figures. Why: The post claims: 1,2TB. Treat group figures as unverified.
- Check regulatory and stakeholder notification duties Health data adds sector rules. This is general guidance, not legal advice: confirm current rules with counsel. Why: The listing or sector points to health data.
Within 30 days
- Check shared suppliers and software List the suppliers and software you share with other Healthcare organizations and ask them whether they were affected. Why: incransom listed 18 other Healthcare organization(s) in the last 90 days.
General readiness for any ransomware claim (not about this listing)
- Offline, immutable backups and a restore drill Keep backups outside domain-admin reach and practise a restore; a leak does not remove the risk of re-encryption. Why: General practice for any ransomware claim; not specific to this listing.
- Look for mass file access and unusual outbound transfers Review EDR, proxy and identity logs for bulk reads, archive creation and large uploads to file-sharing services. Why: General practice for any ransomware claim; not specific to this listing.
- Phishing-resistant MFA on remote access Enforce MFA on VPN, SSO and admin panels, and retire password-only or SMS-based remote access. Why: General practice for any ransomware claim; not specific to this listing.
Listing details
Listing severity score (heuristic)
100/100 • CRITICALA heuristic built from sector, group, data volume and claim details. It is not evidence that a breach occurred or a measure of harm.
External Attack Surface Profile
ASM IntelligenceRun a free passive scan on your own domain to see what an attacker can see from the outside.